Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Kjell Gunnar Gundersen, ESCRS Winter 2022: Simulated Mini-monovision Using a Non-diffractive Extended Vision Intraocular Lens

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Mar 17th 2022

touchOPHTHALMOLOGY had the pleasure of meeting with Dr Kjell Gunnar Gundersen (IFocus Eye Clinic AS, Haugesund, Norway). Dr Gundersen discusses his presentation at the ESCRS Winter 2022 conference on his systematic study on binocular defocus curves.

Questions: 

  1.     Please can you briefly describe the key features of a non-diffractive extended vision intraocular lens (IOL) in comparison with existing IOLs? 00:22-01:45
  2.     What are the pros and cons of using a mini-monovision approach with IOLs? 01:45-04:13
  3.     Please outline the key objectives of methodology used in your systematic study? 04:13-06:00
  4.     What were the main study results? 06:00-06:52
  5.     In your opinion, what are the implications of this study’s results for patients? 06:50-08:11

Disclosures: Kjell Gunnar Gundersen has been a consultant for: Alcon, Glaukos, Santen, 1stQ, Centricity, Ora and Staar. He has received grant/research support from: Alcon. He has been a member of the Advisory Board for: Alcon, Santen, Ora. He has received honoraria/honorarium from: Alcon, Santen, Glaukos and Ora. He has been a Speaker’s Bureau participant with: Alcon, Santen, Glaukos and 1stQ.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Sohpie Nickelson.

Filmed in coverage of the ESCRS Winter 2022 meeting

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup